Ticker: VRDN

Company: Viridian Therapeutics, Inc.\DE

Person: Jennifer Tousignant, officer

Transaction date: Aug. 19, 2026

Reporting date: Aug. 20, 2026

Average share price: 48.45536562203229

Sold 4212.0 shares for 204094.0